Image

Self-monitoring of the Intraocular Pressure Versus Hospital-based Diurnal Monitoring

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

Glaucoma remains the leading cause of irreversible blindness worldwide. Glaucoma represents a group of diseases that lead to optic nerve damage and corresponding deterioration of the visual field.

Elevated intraocular pressure remains the most important risk factor. Interestingly, glaucomatous damage sometimes occurs despite seemingly normal intraocular pressure.

Recent studies suggest pressure peaks, which are missed under the current practice of spot intraocular measurements during office hours. In order to detect pressure peaks diurnal measurements are mandatory. Costly in-hospital diurnal measurements are the current standard.

The primary study objective is to verify that self-tonometry at home can provide valuable information when looking for pressure peaks in patients with glaucoma.

Eligibility

Inclusion Criteria:

  • Informed consent
  • Subjects aged 18 and older
  • Glaucoma patients and healthy controls
  • Best corrected visual acuity >0.1
  • Astigmatism ≤ 3dpt.
  • Good compliance
  • Central corneal thickness (400-650μm)
  • Passed certification procedure (detailed description under: Measurements and procedures)
  • Therapeutic regimen unchanged throughout the past 30 days

Exclusion Criteria:

  • History of ocular trauma
  • Corneal condition interfering with tonometry (keratoconus, corneal scaring) Visual acuity <0.1
  • Physical or mental disability interfering with self-tonometry (e.g. arthritis, Parkinson's disease)
  • Dry eye disease
  • Known or suspected non-compliance, drug or alcohol abuse
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
  • Pregnancy
  • Breastfeeding

Study details

Intraocular Pressure

NCT04485897

Luzerner Kantonsspital

7 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.